CureVac Current Ratio 2021-2021 | CVAC
CureVac current ratio from 2021 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
|CureVac Current Ratio Historical Data
||Medical - Biomedical and Genetics
CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.